Dr. Ann Marie Egloff
Lead Investigator and Assistant Professor in Academic Cancer Research
Pittsburgh, PA
Message
Connect
Profile:
Summary
Dr. Ann Marie Egloff was born in Owosso, Michigan, into a family that deeply valued education and community engagement. Her mother, a science teacher, and her father, a school administrator, inspired a strong sense of academic pursuit and giving back to the community. She excelled academically at Swartz Creek High School, particularly in math and science, earning honors. In addition to her academic achievements, she was involved in sports, including varsity basketball, track and field, and diving, and contributed to student council, theater, and ballet.
Dr. Egloff pursued her higher education at the University of Michigan, earning a Bachelor of Science in Cellular and Molecular Biology. This academic foundation led her to begin her career in biomedical research at Warner-Lambert Parke-Davis. She worked on molecular cloning and studied small-molecule inhibitors for treating cancer and metabolic diseases, receiving recognition for her contributions during her time there.
Driven by a passion for scientific inquiry, Dr. Egloff pursued a PhD in Biochemistry, Cell, and Molecular Biology at Johns Hopkins School of Medicine. Her research focused on immune cell signaling pathways essential for understanding the body's disease responses. After earning her PhD, she completed a postdoctoral fellowship at the National Human Genome Research Institute, where she studied cancer-causing gene mutations, gaining recognition for her impactful work in cancer research.
Her career progressed at the University of Pittsburgh, where she participated in an NIH/NCI-sponsored Cancer Education and Career Development Program. In this role, she worked on translating laboratory discoveries into clinical applications, particularly focusing on personalized cancer treatments. As an Assistant Professor at the University of Pittsburgh School of Medicine, she led research efforts on head and neck cancers and contributed to developing targeted therapies.
In 2015, Dr. Egloff moved to Boston University, where she expanded her research and mentorship responsibilities. She currently works at Brigham and Women's Hospital and Harvard Medical School, focusing on tumor immunology and the development of precision medicine in cancer treatment.
Dr. Ann Marie Egloff's work continues to impact cancer research profoundly. Her ongoing commitment to scientific discovery and mentorship has helped shape the next generation of researchers. She remains dedicated to advancing patient care through her research and community involvement.
